Discontinuation report CODEINE PHOSPHATE INJECTION USP

Last updated on 2022-04-20 History
Report ID 159064
Drug Identification Number 00544884
Brand name CODEINE PHOSPHATE INJECTION USP
Common or Proper name CODEINE PHOSPHATE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) CODEINE PHOSPHATE
Strength(s) 30MG
Dosage form(s) LIQUID
Route of administration SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR
Packaging size 1ML 10LIAM
ATC code R05DA
ATC description COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2022-04-20
Remaining supply date 2022-04-20
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2022-04-20 French Compare
v1 2022-04-20 English Compare

Showing 1 to 2 of 2